Alivexis
Latest round
- Series D
Last raised
- Jan 2025
Total raised
- $5.1M
Investors
- 3
About Alivexis
Alivexis, Inc.Alivexis, Inc. specializes in the development of innovative therapeutics, founded in 2017 in Tokyo, Japan. The company has completed 1 deal to date, with the most recent transaction occurring on January 7, 2025.Alivexis, Inc. specializes in the development of small-molecule targeted therapeutics, leveraging its proprietary technology platform and extensive biological insights. The company focuses on addressing challenging biological targets through advanced structural analysis and supercomputing technologies, which enhance the precision and efficacy of their therapeutic candidates. These products are designed to accelerate the delivery of innovative treatments to patients and families facing serious medical conditions.Alivexis, Inc. generates revenue through strategic partnerships and collaborations within the pharmaceutical and biotechnology sectors. The company engages in direct business transactions with clients that may involve licensing agreements for its therapeutic candidates or collaborative research initiatives. Revenue streams are structured around milestone payments, royalties from successful drug developments, and potential subscription models for ongoing access to their technology platform.In January 2025, Alivexis, Inc. Furthermore, Alivexis aims to expand into new markets, particularly targeting regions in Europe and Asia by 2026, thereby increasing its global footprint in the biotechnology sector.
Who invested in Alivexis
3 investors across 1 round
See all investors in Alivexis
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series D
Jan 7, 2025
Amount
$5.1M
Investors
Questions about Alivexis
Who invested in Alivexis?
Alivexis has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Alivexis raised?
Alivexis has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Alivexis last raise money?
Alivexis's most recent round on record is a Series D, in Jan 2025.
What does Alivexis do?
Alivexis is a biotechnology company.
Where is Alivexis headquartered?
Alivexis is headquartered in Tokyo, Japan.
Which VCs invest in companies like Alivexis?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Alivexis's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Alivexis? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.